# FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION

Source: https://welltoldgrants.com/grants/dct-dct-26-001-fy-2026-drug-court-training-and-technical-assistance/  
Official notice: https://www.grants.gov/search-results-detail/363191

> Office of National Drug Control Policy offered grants of up to $6.0 million (at least $6.0 million) to nonprofits. It expected to make one award worth $6.0 million in total. Applications closed on August 27, 2026.

| Field | Value |
|---|---|
| Opportunity number | DCT-DCT-26-001 |
| Agency | Office of National Drug Control Policy |
| Status | Forecast |
| Deadline | August 27, 2026 |
| Award ceiling | $6.0 million |
| Award floor | $6.0 million |
| Expected awards | 1 |
| Total funding | $6.0 million |
| Cost sharing | not required |
| Assistance Listings | 95.005 |

## Who can apply

- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

## What the grant funds

ONDCP’s Drug Court Training and Technical Assistance Cooperative Agreement supports training and technical assistance (TTA) to ensure access to evidence-based addiction treatment through drug courts, including when substance use disorder co-occurs with other mental healthconditions. ONDCP seeks to reduce drug use and its consequences through evidence-based treatment that leads to long-term recovery, and this cooperative agreement will support the President’s priorities by applying this to the criminal justice system. The purpose of this cooperative agreement is to: (1) educate, train, and produce materials to improve the implementation of evidence-based treatment to individuals with addiction, including when substance use disorder co-occurs with other mental health conditions; (2)decrease criminal justice costs and recidivism rates; and (3) improve access to evidence-based addiction treatment that includes medications for opioid use disorder through drug courts. The cooperative agreement recipient shall:• Use expert practitioners in the science of addiction and evidence-based addiction treatment, as well as integration of treatment into the criminal justice system.• Use licensed behavioral health practitioners.• Provide in-person training, online training, and jurisdiction-specific technical assistanceto a wide range of geographically distributed areas—including rural locations—at thestate, local, and tribal levels.• Ensure close alignment of all TTA materials with the Trump Administration’s policy priorities, including the 2026 National Drug Control Strategy; an evidence-based approach to treating addiction--to include FDA-approved medications for opioid use disorder--contingency management, and other evidence-based behavioral health modalities for other substance use disorders; naloxone distribution and naloxone training.• Designate and fund a research or academic organization to conduct an independent assessment of the effectiveness and impact of training and technical assistance conducted under this cooperative agreement. The independent study should involve data collectionfrom state, local, and tribal jurisdictions engaged in cooperative agreement recipient programming.

## Questions people ask

### Is DCT-DCT-26-001 still open?

No. It closed on August 27, 2026.

### Who can apply for FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION?

Office of National Drug Control Policy accepted applications from nonprofits.

### What is the deadline for FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION?

Closed August 27, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $6.0 million each. About $6.0 million in total for one award.

### Who has won Drug Court Training and Technical Assistance grants before?

The largest recipients over five fiscal years were All Rise for Justice. The program made 5 awards worth $16.9 million in that time.